it is an important September and just cleared our biggest GLP hurdle. We are 90 percent there just before human trials. The drug works and it’s now proving up its safety on a new drug class with nothing out there for TBI. 9 million market cap with peers on safety succes over 100 million market cap the upside will come as the company progresses
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)